Jazz Pharmaceuticals plc — Director's Dealing 2023

Jun 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2023-06-07

Reporting Person: Carr Patricia (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-07	Ordinary Shares	S	126	$127.916	Disposed	6286	Direct

Footnotes

F1: The Reporting Person acquired 126 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 31, 2023.